Development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan

Abstract Objective In the diabetes treatment policy after the Kumamoto Declaration 2013, it is difficult to accurately predict the incidence of complications in patients using the JJ risk engine. This study was conducted to develop a prediction equation suitable for the current diabetes treatment po...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yasunari Yamashita, Gaku Inoue, Yoichi Nozaki, Rina Kitajima, Kiyoshi Matsubara, Takeshi Horii, Junichi Mohri, Koichiro Atsuda, Hajime Matsubara
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
R
Acceso en línea:https://doaj.org/article/61b1872f126e424088b10679d51a780c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:61b1872f126e424088b10679d51a780c
record_format dspace
spelling oai:doaj.org-article:61b1872f126e424088b10679d51a780c2021-11-28T12:25:00ZDevelopment and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan10.1186/s13104-021-05844-w1756-0500https://doaj.org/article/61b1872f126e424088b10679d51a780c2021-11-01T00:00:00Zhttps://doi.org/10.1186/s13104-021-05844-whttps://doaj.org/toc/1756-0500Abstract Objective In the diabetes treatment policy after the Kumamoto Declaration 2013, it is difficult to accurately predict the incidence of complications in patients using the JJ risk engine. This study was conducted to develop a prediction equation suitable for the current diabetes treatment policy using patient data from Kitasato University Kitasato Institute Hospital (Hospital A) and to externally validate the developed equation using patient data from Kitasato University Hospital (Hospital B). Outlier tests were performed on the patient data from Hospital A to exclude the outliers. Prediction equation was developed using the patient data excluding the outliers and was subjected to external validation. Results By excluding outlier data, we could develop a new prediction equation for the incidence of coronary heart disease (CHD) as a complication of type 2 diabetes, incorporating the use of antidiabetic drugs with a high risk of hypoglycemia. This is the first prediction equation in Japan that incorporates the use of antidiabetic drugs. We believe that it will be useful in preventive medicine for treatment for people at high risk of CHD as a complication of diabetes or other diseases. In the future, we would like to confirm the accuracy of this equation at other facilities.Yasunari YamashitaGaku InoueYoichi NozakiRina KitajimaKiyoshi MatsubaraTakeshi HoriiJunichi MohriKoichiro AtsudaHajime MatsubaraBMCarticleJJ risk engineType 2 diabetesCoronary heart diseaseDiscriminationCalibrationHypoglycemiaMedicineRBiology (General)QH301-705.5Science (General)Q1-390ENBMC Research Notes, Vol 14, Iss 1, Pp 1-6 (2021)
institution DOAJ
collection DOAJ
language EN
topic JJ risk engine
Type 2 diabetes
Coronary heart disease
Discrimination
Calibration
Hypoglycemia
Medicine
R
Biology (General)
QH301-705.5
Science (General)
Q1-390
spellingShingle JJ risk engine
Type 2 diabetes
Coronary heart disease
Discrimination
Calibration
Hypoglycemia
Medicine
R
Biology (General)
QH301-705.5
Science (General)
Q1-390
Yasunari Yamashita
Gaku Inoue
Yoichi Nozaki
Rina Kitajima
Kiyoshi Matsubara
Takeshi Horii
Junichi Mohri
Koichiro Atsuda
Hajime Matsubara
Development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan
description Abstract Objective In the diabetes treatment policy after the Kumamoto Declaration 2013, it is difficult to accurately predict the incidence of complications in patients using the JJ risk engine. This study was conducted to develop a prediction equation suitable for the current diabetes treatment policy using patient data from Kitasato University Kitasato Institute Hospital (Hospital A) and to externally validate the developed equation using patient data from Kitasato University Hospital (Hospital B). Outlier tests were performed on the patient data from Hospital A to exclude the outliers. Prediction equation was developed using the patient data excluding the outliers and was subjected to external validation. Results By excluding outlier data, we could develop a new prediction equation for the incidence of coronary heart disease (CHD) as a complication of type 2 diabetes, incorporating the use of antidiabetic drugs with a high risk of hypoglycemia. This is the first prediction equation in Japan that incorporates the use of antidiabetic drugs. We believe that it will be useful in preventive medicine for treatment for people at high risk of CHD as a complication of diabetes or other diseases. In the future, we would like to confirm the accuracy of this equation at other facilities.
format article
author Yasunari Yamashita
Gaku Inoue
Yoichi Nozaki
Rina Kitajima
Kiyoshi Matsubara
Takeshi Horii
Junichi Mohri
Koichiro Atsuda
Hajime Matsubara
author_facet Yasunari Yamashita
Gaku Inoue
Yoichi Nozaki
Rina Kitajima
Kiyoshi Matsubara
Takeshi Horii
Junichi Mohri
Koichiro Atsuda
Hajime Matsubara
author_sort Yasunari Yamashita
title Development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan
title_short Development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan
title_full Development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan
title_fullStr Development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan
title_full_unstemmed Development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in Japan
title_sort development and validation of an equation to predict the incidence of coronary heart disease in patients with type 2 diabetes in japan
publisher BMC
publishDate 2021
url https://doaj.org/article/61b1872f126e424088b10679d51a780c
work_keys_str_mv AT yasunariyamashita developmentandvalidationofanequationtopredicttheincidenceofcoronaryheartdiseaseinpatientswithtype2diabetesinjapan
AT gakuinoue developmentandvalidationofanequationtopredicttheincidenceofcoronaryheartdiseaseinpatientswithtype2diabetesinjapan
AT yoichinozaki developmentandvalidationofanequationtopredicttheincidenceofcoronaryheartdiseaseinpatientswithtype2diabetesinjapan
AT rinakitajima developmentandvalidationofanequationtopredicttheincidenceofcoronaryheartdiseaseinpatientswithtype2diabetesinjapan
AT kiyoshimatsubara developmentandvalidationofanequationtopredicttheincidenceofcoronaryheartdiseaseinpatientswithtype2diabetesinjapan
AT takeshihorii developmentandvalidationofanequationtopredicttheincidenceofcoronaryheartdiseaseinpatientswithtype2diabetesinjapan
AT junichimohri developmentandvalidationofanequationtopredicttheincidenceofcoronaryheartdiseaseinpatientswithtype2diabetesinjapan
AT koichiroatsuda developmentandvalidationofanequationtopredicttheincidenceofcoronaryheartdiseaseinpatientswithtype2diabetesinjapan
AT hajimematsubara developmentandvalidationofanequationtopredicttheincidenceofcoronaryheartdiseaseinpatientswithtype2diabetesinjapan
_version_ 1718407957250572288